Detalles de la búsqueda
1.
Optimizing disease progression assessment using blinded central independent review and comparing it with investigator assessment in the PRIMA/ENGOT-ov26/GOG-3012 trial: challenges and solutions.
Int J Gynecol Cancer
; 33(11): 1733-1742, 2023 11 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37931976
2.
Outcomes after targeted treatment based on somatic tumor genetic testing for women with gynecologic cancers.
Gynecol Oncol
; 163(2): 220-228, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34511240
3.
Malignant bowel obstruction due to uterine or ovarian cancer: Are there differences in outcome?
Gynecol Oncol
; 154(1): 177-182, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31056111
4.
Clinical outcomes in ovarian cancer patients receiving three versus more cycles of chemotherapy after neoadjuvant treatment and interval cytoreductive surgery.
Int J Gynecol Cancer
; 29(7): 1156-1163, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31352365
5.
Bilateral salpingectomy with delayed oophorectomy for ovarian cancer risk reduction: A pilot study in women with BRCA1/2 mutations.
Gynecol Oncol
; 150(1): 79-84, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29735278
6.
Is carboplatin-based chemotherapy as effective as cisplatin-based chemotherapy in the treatment of advanced-stage dysgerminoma in children, adolescents and young adults?
Gynecol Oncol
; 150(2): 253-260, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29884437
7.
Surgical outcomes among elderly women with endometrial cancer treated by laparoscopic hysterectomy: a NRG/Gynecologic Oncology Group study.
Am J Obstet Gynecol
; 218(1): 109.e1-109.e11, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29037481
8.
Ovarian Yolk Sac Tumors; Does Age Matter?
Int J Gynecol Cancer
; 28(1): 77-84, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29194189
9.
Venous Thromboembolism in Patients Receiving Extended Pharmacologic Prophylaxis After Robotic Surgery for Endometrial Cancer.
Int J Gynecol Cancer
; 27(8): 1774-1782, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28708786
10.
Patterns and utility of routine surveillance in high grade endometrial cancer.
Gynecol Oncol
; 137(3): 485-9, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25838164
11.
Combination cediranib and olaparib versus olaparib alone for women with recurrent platinum-sensitive ovarian cancer: a randomised phase 2 study.
Lancet Oncol
; 15(11): 1207-14, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25218906
12.
Gynecologic Cancer InterGroup (GCIG) consensus review for squamous cell carcinoma of the ovary.
Int J Gynecol Cancer
; 24(9 Suppl 3): S26-9, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25126954
13.
Cytochrome P450 inhibitor/inducer treatment patterns among patients in the United States with advanced ovarian cancer who were prescribed or were eligible for poly(adenosine diphosphate [ADP]-ribose) polymerase inhibitors in the first-line maintenance setting.
Gynecol Oncol Rep
; 51: 101332, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38362364
14.
Insights into the field carcinogenesis of ovarian cancer based on the nanocytology of endocervical and endometrial epithelial cells.
Int J Cancer
; 133(5): 1143-52, 2013 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23436651
15.
Adolescents and Young Adults With a "Rare" Cancer: Getting Past Semantics to Optimal Care for Patients With Germ Cell Tumors.
Oncologist
; 23(2): 272, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29449513
16.
Treatment Patterns and Outcomes Among Patients With Advanced or Recurrent Endometrial Cancer Initiating First-Line Therapy in the United States.
J Health Econ Outcomes Res
; 10(2): 82-90, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37905183
17.
Real-world Outcomes Associated With Poly(ADP-ribose) Polymerase Inhibitor Monotherapy Maintenance in Patients With Primary Advanced Ovarian Cancer.
Am J Clin Oncol
; 46(7): 314-322, 2023 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37106485
18.
Omitting lymphadenectomy in patients with endometrial cancer.
Cancer
; 123(2): 197-199, 2017 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28067947
19.
Nonsteroidal antiinflammatory drugs and progestins synergistically enhance cell death in ovarian epithelial cells.
Am J Obstet Gynecol
; 206(3): 253.e1-9, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22206747
20.
Real-world utilization and outcomes of systemic therapy among patients with advanced or recurrent endometrial cancer in the United States.
Curr Med Res Opin
; 38(11): 1935-1945, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35975577